Journal of Neuro-Oncology

, 89:239 | Cite as

Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas

  • Minoru Miyashita
  • Shin-Ichi MiyatakeEmail author
  • Yoshio Imahori
  • Kunio Yokoyama
  • Shinji Kawabata
  • Yoshinaga Kajimoto
  • Masa-Aki Shibata
  • Yoshinori Otsuki
  • Mitsunori Kirihata
  • Koji Ono
  • Toshihiko Kuroiwa
Clinical-Patient Studies


Here we demonstrate that differentiation between glioblastoma (GB) tumor progression (TP) and radiation necrosis (RN) can be achieved with fluoride-labeled boronoalanine positron emission tomography (F-BPA-PET). F-BPA-PET images were obtained from histologically verified 38 GB, 8 complete RN, and 5 RN cases with partial residual tumors. The lesion/normal (L/N) ratios for these groups were 4.2 ± 1.4, 1.5 ± 0.3, and 2.0 ± 0.3, respectively. Ten GB patients underwent F-BPA-PET twice (once before and once after radiation treatment) due to enlargement of the original lesion or the development of new lesions post radiation. The L/N ratios of ten original site lesions had decreased by the second PET, and these lesions were revealed to be RN. In contrast, the L/N ratios of two lesions distant from the original site increased, and these lesions were revealed as cases of TP. Repeat PET imaging was found to be useful for evaluating changes in GB-associated tumor activity with respect to the treatment received.


Boronophenylalanine Glioblastoma Positron emission tomography Radiation necrosis 



This work was partly supported by a Grant-in-Aid for Scientific Research (B) (16390422, 19390385) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to Shin-Ichi Miyatake. This work was also supported in part by the Takeda Science Foundation for Osaka Medical College. We are also grateful to Mr. Horii at Nishijin Hospital for technical support with the PET study.


  1. 1.
    Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA (2006) Intensity-modulated radiotherapy in high-grade gliomas; clinical and dosimetric results. Int J Radiat Oncol Biol Phys 64:892–897PubMedGoogle Scholar
  2. 2.
    Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masunaga S, Nagata K, Maruhashi A, Ono K (2005) Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg 103:1000–1009PubMedGoogle Scholar
  3. 3.
    Iuchi T, Hatano K, Narita Y, Kodama T, Yamaki T, Osato K (2006) Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys 64:1317–1324PubMedGoogle Scholar
  4. 4.
    Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T (2005) High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Lancet Oncol 6:953–960PubMedCrossRefGoogle Scholar
  5. 5.
    Burger P, Boyko O (1991) The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. Raven Press, New York, pp 191–208Google Scholar
  6. 6.
    Delanian S, Balla-Mekias S, Lefaix JL (1999) Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17:3283–3290PubMedGoogle Scholar
  7. 7.
    DiLorenzo N, Nolletti A, Palma L (1978) Late cerebral radionecrosis. Surg Neurol 10:281–290Google Scholar
  8. 8.
    Eyster EF, Nielsen SL, Sheline GE, Wilson CB (1974) Cerebral radiation necrosis simulating a brain tumor. Case report. J Neurosurg 40:267–271PubMedGoogle Scholar
  9. 9.
    Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44:2020–2027PubMedGoogle Scholar
  10. 10.
    Kusske JA, Williams JP, Garcia JH, Pribram HW (1976) Radiation necrosis of the brain following radiotherapy of extracerebral neoplasms. Surg Neurol 6:15–20PubMedGoogle Scholar
  11. 11.
    Martins AN, Johnston JS, Henry JM, Stoffel TJ, Di Chiro G (1977) Delayed radiation necrosis of the brain. J Neurosurg 47:336–345PubMedGoogle Scholar
  12. 12.
    Rizzoli HV, Pagnanelli DM (1984) Treatment of delayed radiation necrosis of the brain. A clinical observation. J Neurosurg 60:589–594PubMedGoogle Scholar
  13. 13.
    Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y (1991) Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D L-phenylalanine: a target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum [A] 42:325–328CrossRefGoogle Scholar
  14. 14.
    Mishima Y, Imahori Y, Honda C, Hiratsuka J, Ueda S, Ido T (1997) In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue. J Neurooncol 33:163–169PubMedCrossRefGoogle Scholar
  15. 15.
    Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, Ido T (1998) Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39:325–333PubMedGoogle Scholar
  16. 16.
    Takahashi Y, Imahori Y, Mineura K (2003) Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas. Clin Cancer Res 9:5888–5895PubMedGoogle Scholar
  17. 17.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRefGoogle Scholar
  18. 18.
    Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin KT, Watson G, Burri S, Stea B (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 58:701–709; discussion 701–709PubMedCrossRefGoogle Scholar
  19. 19.
    Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY (2007) Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67:1135–1144PubMedGoogle Scholar
  20. 20.
    Kawabata S, Miyatake S, Kajimoto Y, Kuroda Y, Kuroiwa T, Imahori Y, Kirihata M, Sakurai Y, Kobayashi T, Ono K (2003) The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases. J Neurooncol 65:159–165PubMedCrossRefGoogle Scholar
  21. 21.
    Miyatake S, Kuroiwa T, Kajimoto Y, Miyashita M, Tanaka H, Tsuji M (2007) Fluorescence of non-neoplastic, MRI-enhancing tissue by 5-aminolevulenic acid: report of 3 cases. Neurosurgery 61:E1101–E1103PubMedCrossRefGoogle Scholar
  22. 22.
    Sonoda Y, Kumabe T, Takahashi T, Shirane R, Yoshimoto T (1998) Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 38:342–347; discussion 347–348CrossRefGoogle Scholar
  23. 23.
    Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54:1111–1117; discussion 1117–1119PubMedCrossRefGoogle Scholar
  24. 24.
    Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D (2006) Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47:1059–1066PubMedGoogle Scholar
  25. 25.
    Meller J, Sahlmann CO, Scheel AK (2007) 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:35–45PubMedGoogle Scholar
  26. 26.
    Burger PC, Mahley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44:1256–1272PubMedCrossRefGoogle Scholar
  27. 27.
    Wang SX, Boethius J, Ericson K (2006) FDG-PET on irradiated brain tumor: ten years’ summary. Acta Radiol 47:85–90PubMedCrossRefGoogle Scholar
  28. 28.
    Hung GU, Tsai SC, Lin WY (2005) Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma. Clin Nucl Med 30:558–559PubMedCrossRefGoogle Scholar
  29. 29.
    Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L (2006) [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 27:1432–1437PubMedGoogle Scholar
  30. 30.
    Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M (2004) Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery – in malignant glioma. Ann Nucl Med 18:291–296PubMedCrossRefGoogle Scholar
  31. 31.
    Laverman P, Boerman OC, Corstens FH, Oyen WJ (2002) Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 29:681–690PubMedCrossRefGoogle Scholar
  32. 32.
    Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R (1998) Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin Cancer Res 4:1825–1832PubMedGoogle Scholar
  33. 33.
    Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R (1998) Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res 4:1833–1841PubMedGoogle Scholar
  34. 34.
    Joensuu H, Kankaanranta L, Seppala T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vahatalo J, Kortesniemi M, Kotiluoto P, Seren T, Karila J, Brander A, Jarviluoma E, Ryynanen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jaaskelainen J, Farkkila M, Savolainen S (2003) Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol 62:123–134PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Minoru Miyashita
    • 1
  • Shin-Ichi Miyatake
    • 1
    Email author
  • Yoshio Imahori
    • 3
  • Kunio Yokoyama
    • 1
  • Shinji Kawabata
    • 1
  • Yoshinaga Kajimoto
    • 1
  • Masa-Aki Shibata
    • 2
  • Yoshinori Otsuki
    • 2
  • Mitsunori Kirihata
    • 4
  • Koji Ono
    • 5
  • Toshihiko Kuroiwa
    • 1
  1. 1.Department of NeurosurgeryOsaka Medical CollegeTakatsukiJapan
  2. 2.Department of Anatomy & Cell BiologyOsaka Medical CollegeTakatsukiJapan
  3. 3.Cancer Intelligence Care System, Inc.TokyoJapan
  4. 4.Department of AgricultureOsaka Prefectural UniversitySakaiJapan
  5. 5.Particle Radiation Oncology Research Center, Research Reactor InstituteKyoto UniversityKumatoriJapan

Personalised recommendations